Global leaders have approved a plan to reduce the estimated 4.95 million human deaths associated with bacterial antimicrobial resistance (AMR) annually by 10% by 2030.

The political declaration was agreed at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR).

Acknowledging that AMR is a complex problem, the declaration recognises the need for a multisectoral response combining human, agricultural, animal, and environmental sector-specific interventions.

The declaration emphasises the importance of access to medicines, treatments and diagnostics, while calling for incentives and financing mechanisms to drive multisectoral health research, innovation and development in addressing AMR.

It argues that a stronger, transparent partnership between the public and private sectors, as well as academia is critical.

Expanding access to antimicrobial medicines

“In the century since Alexander Fleming stumbled across penicillin in a laboratory in London, antibiotics have become a mainstay of medicine, transforming once-deadly infections into treatable and curable conditions,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “AMR threatens to unwind that progress, making it without question one of the most pressing health challenges of our time. Today’s declaration includes vital commitments that, if translated into action, will help to track AMR, slow it down, expand access to antimicrobial medicines like antibiotics and spur the development of new ones.”

The declaration sets a target that at least 70% of antibiotics used for human health globally should belong to the WHO Access group antibiotics with relatively minimal side effects and lower potential to cause AMR.

Commenting on the UN AMR Declaration, Colette Goldrick, ABPI Executive Director Corporate Affairs & Strategy, said: “This UN Declaration means there is renewed international recognition of the threat that antimicrobial resistance poses to global health and the need for different countries to collaborate on solutions, including their Action Plans. The UK has already demonstrated international leadership on this issue by launching a world-first new model for evaluating and paying for antibiotics and a new National Action Plan on AMR.

“We will continue to partner with the government to share the positive lessons from the UK with other nations and to find meaningful and long-term solutions to this ongoing silent global epidemic.”

The declaration also calls for sustainable national financing and $100 million in funding, to help achieve a target of at least 60% of countries having funded national action plans on AMR by 2030.

Diana Spencer, Senior Digital Content Editor, DDW